Related references
Note: Only part of the references are listed.p53 activation during ribosome biogenesis regulates normal erythroid differentiation
Salome Le Goff et al.
BLOOD (2021)
Two patients with MIRAGE syndrome lacking haematological features: role of somatic second-site reversion SAMD9 mutations
Hirohito Shima et al.
JOURNAL OF MEDICAL GENETICS (2018)
Polε Instability Drives Replication Stress, Abnormal Development, and Tumorigenesis
Roberto Bellelli et al.
MOLECULAR CELL (2018)
DNA Polymerase Epsilon Deficiency Causes IMAGe Syndrome with Variable Immunodeficiency
Clare Logan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
A patient with polymerase E1 deficiency (POLE1): clinical features and overlap with DNA breakage/instability syndromes
Isabelle Thiffault et al.
BMC MEDICAL GENETICS (2015)
Bone Marrow Failure in Fanconi Anemia Is Triggered by an Exacerbated p53/p21 DNA Damage Response that Impairs Hematopoietic Stem and Progenitor Cells
Raphael Ceccaldi et al.
CELL STEM CELL (2012)
Polymerase ε1 mutation in a human syndrome with facial dysmorphism, immunodeficiency, livedo, and short stature (FILS syndrome)
Jana Pachlopnik Schmid et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells
Shilpee Dutt et al.
BLOOD (2011)
A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q-syndrome
Jillian L. Barlow et al.
NATURE MEDICINE (2010)
The Fanconi Anemia/BRCA pathway: new faces in the crowd
RD Kennedy et al.
GENES & DEVELOPMENT (2005)
Share Paper
